Buy Acadia Healthcare

Logo for stock ACHC (Acadia Healthcare)

Amount

£
GBP

Latest price

$42.85
(£1.00 = $1.236)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$3.98B

P/E ratio

14.02

EPS

$3.056

Beta

1.33

Dividend rate

N/A

Dividend yield

N/A

About

Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States. Its facilities and services are classified into various categories: acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs) and residential treatment centers. Outpatient programs associated with its facilities are included within each respective service line. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. It operates over 13 CTC locations in North and South Carolina and 165 locations in 33 states across the country. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The Company operates over 258 behavioral healthcare facilities with 11,400 beds in 38 states and Puerto Rico.

CEO

Mr. Christopher H. (Chris) Hunter

Employees

17,000

Sector

Health

Company HQ

FRANKLIN, United States of America

News

Logo for news article #0 (Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Acadia Healthcare Company, Inc. (ACHC) and Encourages Stockholders to Learn More About the Investigation)

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Acadia Healthcare Company, Inc. (ACHC) and Encourages Stockholders to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Accesswire

February 09, 2025

Logo for news article #1 (Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2024 Earnings Release)

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2024 Earnings Release

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2024 results on Thursday, February 27, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Friday, February 28, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the.

Business Wire

February 06, 2025

Logo for news article #2 (INVESTIGATION ALERT (NASDAQ: ACHC): DiCello Levitt LLP Is Investigating Investor Claims Against Acadia Healthcare Company, Inc. and Encourages Current ACHC Shareholders to Contact the Firm)

INVESTIGATION ALERT (NASDAQ: ACHC): DiCello Levitt LLP Is Investigating Investor Claims Against Acadia Healthcare Company, Inc. and Encourages Current ACHC Shareholders to Contact the Firm

SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether certain directors of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) (“Defendants”) breached their fiduciary duties owed to shareholders, including during the period February 28, 2020 through the present.

GlobeNewsWire

February 05, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2025 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies Ltd is an Introducer Appointed Representative of Quint Group Limited, which is authorised and regulated by the Financial Conduct Authority (FRN 669450). Emma Technologies Ltd is not a lender. Emma Technologies Ltd introduces customers to Monevo Limited who is a licensed credit broker.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.